Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Forest potentially boosts GI portfolio with $1bn buy of Furiex

Executive Summary

Just two months after Actavis PLC announced it bought Forest Laboratories Inc. for $23.9bn, Forest is making an acquisition itself, taking over publicly traded biotech Furiex Pharmaceuticals Inc. for $1bn up front in cash, or $95/share (a 20% premium).

Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Includes Earnout
    • Payment Includes Cash for Equity

Related Companies